INTENSIVE THERAPY AND ICU ADMISSION IN COMMUNITY ACQUIRED PNEUMONIA (CAP).

被引：0
|
作者：
Brown, Samuel [1 ]
Jones, Barbara [1 ]
Jephson, Al [1 ]
Dalto, Joe [1 ]
Crapo, Susan [1 ]
Martial, Marc-Aurel [1 ]
Dean, Nathan [1 ]
机构：
[1] Intermt Med Ctr, Salt Lake City, UT USA
来源：
CRITICAL CARE MEDICINE | 2008年 / 36卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
403
引用
收藏
页码：A99 / A99
页数：1
相关论文
共 50 条
  • [41] Procalcitonin and community-acquired pneumonia (CAP) in children
    Giulia, Bivona
    Luisa, Agnello
    Concetta, Scazzone
    Bruna, Lo Sasso
    Chiara, Bellia
    Marcello, Ciaccio
    CLINICA CHIMICA ACTA, 2015, 451 : 215 - 218
  • [42] The impact of mixed etiology in community acquired pneumonia (CAP)
    Montull, Beatriz
    Menendez, Rosario
    Mendez, Raul
    Torres, Toni
    Reyes, Soledad
    Zalacain, Rafael
    Capelastegui, Alberto
    Aspa, Javier
    Borderias, Luis
    Martin-Villasclaras, Juan
    Bello, Salvador
    Alfageme, Inmaculada
    Rodriguez-de-Castro, Felipe
    Rello, Jordi
    Molinos, Luis
    Ruiz-Manzano, Juan
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [43] Osteopontin role in community-Acquired Pneumonia (CAP)
    Sharshar, Ragia
    Ibrahim, Ibrahim
    Mohamed, Ahmed
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [44] Cardiac diseases in patients with community acquired pneumonia (CAP)
    Murali, B. V.
    Ranganatha, R.
    Sen, Tiyas
    Malapaka, Ravi Chandra
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [45] Biomarkers and severity in community-acquired pneumonia (CAP)
    Fandos, Sergio
    Minchole, Elisa
    Lasierra, Ana
    Simon, Ana
    Panadero, Carolina
    Hernandez, Guillermo
    De Pablo, Francisco
    Garcia, Sandra
    Lapresta, Carlos
    Bello, Salvador
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [46] Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD)
    Demchuk, Hanna
    Mostovoy, Yuriy
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [47] Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP)
    Kireeva, Tetyana
    Bielosludtseva, Kseniia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [48] 13 - Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents
    Roig, J.
    Casal, J.
    Gispert, P.
    Gea, E.
    MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (11-12): : 680 - 689
  • [49] THE IMPACT OF COAGULATION PARAMETERS ON THE OUTCOMES OF PATIENTS WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA REQUIRING ICU ADMISSION
    Rabello, L.
    Rosolem, M.
    Salluh, J.
    Soares, M.
    Bozza, F.
    Verdeal, J. C.
    Mello, G.
    Castro-Faria-Neto, H.
    Lapa e Silva, J. R.
    Bozza, P.
    INTENSIVE CARE MEDICINE, 2010, 36 : S343 - S343
  • [50] HOW CAN WE PREDICT OUTCOME AT ICU ADMISSION IN PATIENTS WITH SEVERE COMMUNITY-ACQUIRED PNEUMONIA?
    Pereira, J. M.
    Pinho, A.
    Artur Paiva, J.
    INTENSIVE CARE MEDICINE, 2010, 36 : S345 - S345
12345